Derm In The News: April 21-27
Keep up with the latest headlines in dermatology from the past week, including the appointment of All Detergent’s first chief dermatology advisor, Incyte’s acquisition of Escient Pharmaceuticals, and more.
Keep up with the latest headlines in dermatology from the past week, including the appointment of All Detergent’s first chief dermatology advisor, Incyte’s acquisition of Escient Pharmaceuticals, and more.
In case you missed it, this week we had news about roflumilast foam’s efficacy in diverse hair types of seborrheic dermatitis, Lindus Health’s new partnership…
Unless you have been under a pile of retention hyperkeratosis, it would be hard to say one has not heard the call to purposefully diversify…
How much do you know about gastroesophageal reflux disease (GERD) and its diagnosis and treatment? In this engaging, interactive symposium, participants will get to test…
Scassellati Sforzolini discusses the significance of Galderma’s nemolizumab receiving 4 additional filing acceptances for prurigo nodularis and atopic dermatitis.
Cre ate a non-member account if you are applying for membership or need to interact with AAD systems. Non-member accounts do not have access to…
In this whitepaper, leading experts in the treatment of patients with psoriatic arthritis (PsA) and axial spondyloarthritis (axSpA) summarize the educational gaps among health care…
Clearly Me uses portraiture to spotlight the journeys of psoriasis patients Katie Lowes, DaQuane Cherry, Ayesha Patrick, and Joanna “JoJo” Pomerantz.
A patient with cognitive impairment has been referred to specialty care; now what? This final webinar in the series explores what to look for in…
Create a non-member account if you are applying for membership or need to interact with AAD systems. Non-member accounts do not have access to the…
It is important dermatologists learn to recognize the clinical findings of dermatophytomas and distinguish them from other onychomycosis subtypes because the recommended treatments differ.